Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Reviews in the Neurosciences

Editor-in-Chief: Huston, Joseph P.

Editorial Board: Topic, Bianca / Adeli, Hojjat / Buzsaki, Gyorgy / Crawley, Jacqueline / Crow, Tim / Gold, Paul / Holsboer, Florian / Korth, Carsten / Lubec, Gert / McEwen, Bruce / Pan, Weihong / Pletnikov, Mikhail / Robbins, Trevor / Schnitzler, Alfons / Stevens, Charles / Steward, Oswald / Trojanowski, John

8 Issues per year


IMPACT FACTOR 2017: 2.590
5-year IMPACT FACTOR: 3.078

CiteScore 2017: 2.81

SCImago Journal Rank (SJR) 2017: 0.980
Source Normalized Impact per Paper (SNIP) 2017: 0.804

Online
ISSN
2191-0200
See all formats and pricing
More options …
Volume 25, Issue 2

Issues

Proinflammatory and anti-inflammatory cytokines in febrile seizures and epilepsy: systematic review and meta-analysis

Amene Saghazadeh
  • Molecular Immunology Research Center; and Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Maryam Gharedaghi / Alipasha Meysamie
  • Department of Community and Preventive Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Sebastian Bauer
  • Klinik für Neurologie, Epilepsiezentrum Hessen (EZH), Philipps-Universität Marburg, Marburg, Germany
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Nima Rezaei
  • Corresponding author
  • Molecular Immunology Research Center; and Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Dr. Qarib Street, Keshavarz Boulevard, Tehran 14194, Iran
  • Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, S10 2TN, UK
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2014-02-07 | DOI: https://doi.org/10.1515/revneuro-2013-0045

Abstract

Activation of proinflammatory and anti-inflammatory cytokines network seems to have a role in febrile seizures (FS). The present meta-analysis was aimed to pool the inconsistent data provided with case-control studies on the relationship of proinflammatory and anti-inflammatory cytokines and FS/epilepsy risk. The genotype interleukin (IL)-1α-889 1/1 (recessive model) was significantly correlated with increased risk of epilepsy (p=0.008) and FS/epilepsy (p=0.004). Patients with IL-1β-511 T/T homozygote were more susceptible to develop FS (p=0.036) but not epilepsy. Furthermore, the T/T genotype was totally associated with increased risk of FS/epilepsy (p=0.043). Although the recessive model was also confirmed for the Asian subgroup (FS and FS/epilepsy), we found a protective effect of C/C genotype toward developing FS in the Caucasian race (p=0.020). The second meta-analysis on cytokine levels showed a statistically higher serum level of IL-6 in patients with epilepsy compared to control subjects without epilepsy. The present meta-analysis showed that two alleles of proinflammatory cytokines (IL-1α-889 and IL-1β-511) in addition to the serum concentration of IL-6 were significantly associated with FS and epilepsy or both in various subgroup analyses.

Keywords: cytokines; epilepsy; febrile seizures

References

  • Abdel Rasol, H.A., Issac, M.S.M., Abdel Ghaffar, H., and El-Mously, S. (2012). Interleukin-1 receptor antagonist and interleukin-1β -511 gene polymorphisms among Egyptian children with febrile seizures. Comp. Clin. Pathol. 1–7. Available at http://link.springer.com/journal/580/onlineFirst/page/11.

  • Akira, S., Hirano, T., Taga, T., and Kishimoto, T. (1990). Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J. 4, 2860–2867.PubMedGoogle Scholar

  • Alapirtti, T., Rinta, S., Hulkkonen, J., Mäkinen, R., Keränen, T., and Peltola, J. (2009). Interleukin-6, interleukin-1 receptor antagonist and interleukin-1beta production in patients with focal epilepsy: a video-EEG study. J. Neurol. Sci. 280, 94–97.CrossrefGoogle Scholar

  • Annegers, J.F., Hauser, W.A., Shirts, S.B., and Kurland, L.T. (1987). Factors prognostic of unprovoked seizures after febrile convulsions. N. Engl. J. Med. 316, 493–498.CrossrefGoogle Scholar

  • Annegers, J.F., Blakley, S.A., Allen Hauser, W., and Kurland, L.T. (1990). Recurrence of febrile convulsions in a population-based cohort. Epilepsy Res. 5, 209–216.CrossrefGoogle Scholar

  • Asano, T., Ichiki, K., Koizumi, S., Kaizu, K., Hatori, T., Fujino, O., Mashiko, K., Sakamoto, Y., Miyasho, T., and Fukunaga, Y. (2010). IL-8 in cerebrospinal fluid from children with acute encephalopathy is higher than in that from children with febrile seizure. Scand. J. Immunol. 71, 447–451.Google Scholar

  • Audenaert, D., Schwartz, E., Claeys, K.G., Claes, L., Deprez, L., Suls, A., Van Dyck, T., Lagae, L., Van Broeckhoven, C., Macdonald, R.L., et al. (2006). A novel GABRG2 mutation associated with febrile seizures. Neurology 67, 687–690.CrossrefGoogle Scholar

  • Balosso, S., Ravizza, T., Perego, C., Peschon, J., Campbell, I.L., De Simoni, M.G., and Vezzani, A. (2005). Tumor necrosis factor-α inhibits seizures in mice via p75 receptors. Ann. Neurol. 57, 804–812.CrossrefGoogle Scholar

  • Banerjee, P.N., Filippi, D., and Hauser, W.A. (2009). The descriptive epidemiology of epilepsy – a review. Epilepsy Res. 85, 31–45.PubMedCrossrefGoogle Scholar

  • Bauer, S., Cepok, S., Todorova-Rudolph, A., Nowak, M., Köller, M., Lorenz, R., Oertel, W.H., Rosenow, F., Hemmer, B., and Hamer, H.M. (2009). Etiology and site of temporal lobe epilepsy influence postictal cytokine release. Epilepsy Res. 86, 82–88.CrossrefPubMedGoogle Scholar

  • Baulac, S., Gourfinkel-An, I., Picard, F., Rosenberg-Bourgin, M., Prud’homme, J.-F., Baulac, M., Brice, A., and LeGuern, E. (1999). A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33. Am. J. Hum. Genet. 65, 1078–1085.Google Scholar

  • Behmanesh, F., Ashrafzadeh, F., Varasteh, A., Shakeri, A., and Shahsavand, S. (2012). Evaluation of interleukin 1beta in febrile convulsion. Iran J. Allergy Asthma Immunol. 11, 336–339.Google Scholar

  • Ben-Ari, Y. (2002). Excitatory actions of GABA during development: the nature of the nurture. Nat. Rev. Neurosci. 3, 728–739.Google Scholar

  • Berkovic, S.F., Howell, R.A., Hay, D.A., and Hopper, J.L. (1998). Epilepsies in twins: genetics of the major epilepsy syndromes. Ann. Neurol. 43, 435–445.CrossrefPubMedGoogle Scholar

  • Billiau, A.D., Witters, P., Ceulemans, B., Kasran, A., Wouters, C., and Lagae, L. (2007). Intravenous immunoglobulins in refractory childhood-onset epilepsy: effects on seizure frequency, EEG activity, and cerebrospinal fluid cytokine profile. Epilepsia 48, 1739–1749.PubMedCrossrefGoogle Scholar

  • Blair, M.A., Ma, S., Abou-Khalil, B., and Hedera, P. (2007). Genetic variants in the IMPA2 gene do not confer increased risk of febrile seizures in Caucasian patients. Eur. J. Neurol. 14, 424–427.CrossrefGoogle Scholar

  • Blyth, C.C., Currie, A.J., Wiertsema, S.P., Conway, N., Kirkham, L.A.S., Fuery, A., Mascaro, F., Geelhoed, G.C., and Richmond, P.C. (2011). Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms. Vaccine 29, 5107–5113.PubMedCrossrefGoogle Scholar

  • Buono, R.J., Ferraro, T.N., O’Connor, M.J., Sperling, M.R., Ryan, S.G., Scattergood, T., Mulholland, N., Gilmore, J., Lohoff, F.W., and Berrettini, W.H. (2001). Lack of association between an interleukin 1beta (IL-1β) gene variation and refractory temporal lobe epilepsy. Epilepsia 42, 782–784.CrossrefGoogle Scholar

  • Camargo, M.C., Mera, R., Correa, P., Peek, R.M., Fontham, E.T.H., Goodman, K.J., Piazuelo, M.B., Sicinschi, L., Zabaleta, J., and Schneider, B.G. (2006). Interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 15, 1674–1687.CrossrefGoogle Scholar

  • Carmeli, E., Beiker, R., and Morad, M. (2009). Nitric oxide and interlukin-6 levels in intellectual disability adults with epilepsy. Res. Dev. Disabil. 30, 567–571.PubMedCrossrefGoogle Scholar

  • Cavalleri, G.L., Lynch, J.M., Depondt, C., Burley, M.-W., Wood, N.W., Sisodiya, S.M., and Goldstein, D.B. (2005). Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here? Brain 128, 1832–1840.PubMedCrossrefGoogle Scholar

  • Cho, S.M., Kim, Y.H., Chung, S.Y., Lee, I.G., Whang, K.T., Lee, B.C., and Lee, K.H. (2005). Single nucleotide polymorphisms of GABRG2 in febrile seizures and GEFS+. J. Kor. Child Neurol. Soc. 13, 144–151.Google Scholar

  • Choi, J., Min, H.J., and Shin, J.-S. (2011). Increased levels of HMGB1 and pro-inflammatory cytokines in children with febrile seizures. J. Neuroinflamm. 8, 135.CrossrefGoogle Scholar

  • Chou, I.-C., Tsai, F.-J., Huang, C.-C., Lin, C.-C., and Tsai, C.-H. (2002). The voltage-gated potassium channel KCNQ2 in Taiwanese children with febrile convulsions. NeuroReport 13, 1971–1973.CrossrefGoogle Scholar

  • Chou, I.C., Lee, C.-C., Huang, C.-C., Wu, J.-Y., Tsai, J.J.P., Tsai, C.-H., and Tsai, F.-J. (2003a). Association of the neuronal nicotinic acetylcholine receptor subunit α4 polymorphisms with febrile convulsions. Epilepsia 44, 1089–1093.Google Scholar

  • Chou, I.C., Peng, C.-T., Huang, C.-C., Tsai, J.J.P., Tsai, F.-J., and Tsai, C.-H. (2003b). Association analysis of γ2 subunit of γ-aminobutyric acid type a receptor polymorphisms with febrile seizures. Pediatr. Res. 54, 26–29.CrossrefPubMedGoogle Scholar

  • Chou, I.C., Tsai, C.H., Hsieh, Y.Y., Peng, C.T., and Tsai, F.J. (2003c). Association between polymorphism of interleukin-1β -511 promoter and susceptibility to febrile convulsions in Taiwanese children. Acta Pediatr. 92, 1356.Google Scholar

  • Chou, I.C., Tsai, C.H., Lee, C.C., Lin, S.S., and Tsai, F.J. (2004). Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in febrile seizures. Epilepsy Res. 60, 27–29.CrossrefGoogle Scholar

  • Chou, I.C., Lin, W.-D., Wang, C.-H., Tsai, C.-H., Li, T.-C., and Tsai, F.-J. (2010). Interleukin (IL)-1β, IL-1 receptor antagonist, IL-6, IL-8, IL-10, and tumor necrosis factor α gene polymorphisms in patients with febrile seizures. J. Clin. Lab. Anal. 24, 154–159.Google Scholar

  • Chung, S.Y., Park, Y.J., Kim, Y.H., Lee, I.G., Whang, K.T., Lee, J.S., Kim, H.S., Lee, K.H., and Yim, S.V. (2006). Interleukin-1beta promoter polymorphisms in febrile seizures and GEFS+. J. Kor. Child Neurol. Soc. 14, 113–120.Google Scholar

  • Conti, B., Tabarean, I., Andrei, C., and Bartfai, T. (2004). Cytokines and fever. Front. Biosci. 9, 1433–1449.PubMedCrossrefGoogle Scholar

  • Corey, L.A., Berg, K., Pellock, J.M., Solaas, M.H., Nance, W.E., and DeLorenzo, R.J. (1991). The occurrence of epilepsy and febrile seizures in Virginian and Norwegian twins. Neurology 41, 1433–1436.PubMedCrossrefGoogle Scholar

  • Cross, J.H. (2012). Fever and fever-related epilepsies. Epilepsia 53, 3–8.CrossrefPubMedGoogle Scholar

  • Dai, X.-H., Chen, W.-W., Wang, X., Zhu, Q.-H., Li, C., Li, L., Liu, M.-G., Wang, Q.-K., and Liu, J.-Y. (2008). A novel genetic locus for familial febrile seizures and epilepsy on chromosome 3q26.2-q26.33. Hum. Genet. 124, 423–429.Google Scholar

  • Dias De Sousa, M.A., Bonatti, R.C.F., Rodrigues V. Jr., Azevedo, D.S., Santos, M.H.A., Pereira, R.O.L., and Leboreiro-Fernandez, A. (2012). Cytokines in cerebrospinal fluid of children with West syndrome. J. Epilepsy Clin. Neurophysiol. 18, 63–66.Google Scholar

  • Dibbens, L.M., Reid, C.A., Hodgson, B., Thomas, E.A., Phillips, A.M., Gazina, E., Cromer, B.A., Clarke, A.L., Baram, T.Z., Scheffer, I.E., et al. (2010). Augmented currents of an HCN2 variant in patients with febrile seizure syndromes. Ann. Neurol. 67, 542–546.CrossrefGoogle Scholar

  • Dinarello, C.A. (2004). Review: Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J. Endotoxin Res. 10, 201–222.Google Scholar

  • Dingledine, R., McBain, C.J., and McNamara, J.O. (1990). Excitatory amino acid receptors in epilepsy. Trends. Pharmacol. Sci. 11, 334–338.CrossrefPubMedGoogle Scholar

  • Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., and Lanctôt, K.L. (2010). A meta-analysis of cytokines in major depression. Biol. Psychiatry 67, 446–457.PubMedCrossrefGoogle Scholar

  • Dubé, C., Vezzani, A., Behrens, M., Bartfai, T., and Baram, T.Z. (2005). Interleukin-1β contributes to the generation of experimental febrile seizures. Ann. Neurol. 57, 152–155.CrossrefGoogle Scholar

  • Dubé, C.M., Brewster, A.L., Richichi, C., Zha, Q., and Baram, T.Z. (2007). Fever, febrile seizures and epilepsy. Trends Neurosci. 30, 490–496.CrossrefPubMedGoogle Scholar

  • Dubé, C.M., Brewster, A.L., and Baram, T.Z. (2009). Febrile seizures: mechanisms and relationship to epilepsy. Brain Dev. 31, 366–371.CrossrefPubMedGoogle Scholar

  • Dubé, C.M., McClelland, S., Choy, M.K., Brewster, A.L., Noam, Y., and Baram, T.Z. (2010). Fever, febrile seizures, and epileptogenesis. Epilepsia 51, 33.CrossrefGoogle Scholar

  • el-Radhi, A.S. and Banajeh, S. (1989). Effect of fever on recurrence rate of febrile convulsions. Arch. Dis. Child 64, 869–870.Google Scholar

  • Evans, C.A.W., Garcia, H.H., Hartnell, A., Gilman, R.H., Jose, P.J., Martinez, M., Remick, D.G., Williams, T.J., and Friedland, J.S. (1998). Elevated concentrations of eotaxin and interleukin-5 in human neurocysticercosis. Infect. Immun. 66, 4522–4525.Google Scholar

  • Fabricio, A.S.C., Silva, C.A.A., Rae, G.A., D’Orléans-Juste, P., and Souza, G.E.P. (1998). Essential role for endothelin ETB receptors in fever induced by LPS (E. coli) in rats. Br. J. Pharmacol. 125, 542–548.Google Scholar

  • French, J.A. (2012). Febrile seizures: possible outcomes. Neurology 79, e80–e82.PubMedCrossrefGoogle Scholar

  • Fukumoto, Y., Okumura, A., Hayakawa, F., Suzuki, M., Kato, T., Watanabe, K., and Morishima, T. (2007). Serum levels of cytokines and EEG findings in children with influenza associated with mild neurological complications. Brain Dev. 29, 425–430.CrossrefPubMedGoogle Scholar

  • Ganor, Y., Freilinger, M., Dulac, O., and Levite, M. (2005). Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokines. Autoimmunity 38, 139–150.PubMedCrossrefGoogle Scholar

  • Gao, B., Hu M.-S., and Zhang, L. (2007). A study on the association of polymorphism of IL-10 with febrile convulsion. Chin. J. Birth Health Hered. 3.Google Scholar

  • Giray, Ö., Ülgenalp, A., Bora, E., Uran, N., Yılmaz, E., Ünalp, A., and Erçal, D. (2008). Role of apolipoprotein E in febrile convulsion. Pediatr. Neurol. 39, 241–244.CrossrefPubMedGoogle Scholar

  • Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy (1993). Epilepsia 34, 592–596.PubMedGoogle Scholar

  • Haberlandt, E., Rauchenzauner, M., Morass, M., Wondrak, P., Burgi, S.S., Rostasy, K., and Karall, D. (2013). Matrix-metalloproteinases and proinflammatory cytokines in children with febrile convulsions and epilepsy-cause or consequence? Epilepsy Res. 105, 225–228.CrossrefPubMedGoogle Scholar

  • Haginoya, K., Noguchi, R., Zhao, Y., Munakata, M., Yokoyama, H., Tanaka, S., Hino-Fukuyo, N., Uematsu, M., Yamamoto, K., Takayanagi, M., et al. (2009). Reduced levels of interleukin-1 receptor antagonist in the cerebrospinal fluid in patients with West syndrome. Epilepsy Res. 85, 314–317.Google Scholar

  • Hahn, L.W., Ritchie, M.D., and Moore, J.H. (2003). Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19, 376–382.PubMedCrossrefGoogle Scholar

  • Hamati-Haddad, A. and Abou-Khalil, B. (1998). Epilepsy diagnosis and localization in patients with antecedent childhood febrile convulsions. Neurology 50, 917–922.CrossrefGoogle Scholar

  • Haspolat, Ş., Mihçi, E., Coşkun, M., Gümüslü, S., Özbenm, T., and Yeğin, O. (2002). Interleukin-1β, tumor necrosis factor-α, and nitrite levels in febrile seizures. J. Child Neurol. 17, 749–751.CrossrefGoogle Scholar

  • Haspolat, Ş., Baysal, Y., Duman, Ö., Coşkun, M., Tosun, Ö., and Yein, O. (2005). Interleukin-1α, interleukin-1β, and interleukin-1Ra polymorphisms in febrile seizures. J. Child Neurol. 20, 565–568.Google Scholar

  • Hedera, P., Ma, S., Blair, M.A., Taylor, K.A., Hamati, A., Bradford, Y., Abou-Khalil, B., and Haines, J.L. (2006). Identification of a novel locus for febrile seizures and epilepsy on chromosome 21q22. Epilepsia 47, 1622–1628.Google Scholar

  • Heida, J.G., Moshé, S.L., and Pittman, Q.J. (2009). The role of interleukin-1β in febrile seizures. Brain Dev. 31, 388–393.Google Scholar

  • Heils, A., Haug, K., Kunz, W.S., Fernandez, G., Horvath, S., Rebstock, J., Propping, P., and Elger, C.E. (2000). Interleukin-1beta gene polymorphism and susceptibility to temporal lobe epilepsy with hippocampal sclerosis. Ann. Neurol. 48, 948–950.Google Scholar

  • Home, P. and Kerirey, S. (1991). Psychosocial adjustment of children with chronic epilepsy and their families. Dev. Med. Child Neurol. 33, 201–215.CrossrefGoogle Scholar

  • Howren, M.B., Lamkin, D.M., and Suls, J. (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 71, 171–186.Google Scholar

  • Hu, M.-H., Huang, G.-S., Wu, C.-T., Lin, J.-J., Hsia, S.-H., Wang, H.-S., and Lin, K.-L. (2014). Analysis of plasma multiplex cytokines for children with febrile seizures and severe acute encephalitis. J. Child Neurol. 29, 182–186CrossrefGoogle Scholar

  • Huang, C.C., Wang, S.T., Chang, Y.C., Huang, M.C., Chi, Y.C., and Tsai, J.J. (1999). Risk factors for a first febrile convulsion in children: a population study in southern Taiwan. Epilepsia 40, 719–725.PubMedCrossrefGoogle Scholar

  • Hulkkonen, J., Koskikallio, E., Rainesalo, S., Keränen, T., Hurme, M., and Peltola, J. (2004). The balance of inhibitory and excitatory cytokines is differently regulated in vivo and in vitro among therapy resistant epilepsy patients. Epilepsy Res. 59, 199–205.CrossrefPubMedGoogle Scholar

  • Ichiyama, T., Nishikawa, M., Yoshitomi, T., Hayashi, T., and Furukawa, S. (1998). Tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 in cerebrospinal fluid from children with prolonged febrile seizures. Comparison with acute encephalitis/encephalopathy. Neurology 50, 407–411.PubMedGoogle Scholar

  • Ichiyama, T., Morishima, T., Isumi, H., Matsufuji, H., Matsubara, T., and Furukawa, S. (2004). Analysis of cytokine levels and NF-κB activation in peripheral blood mononuclear cells in influenza virus-associated encephalopathy. Cytokine 27, 31–37.PubMedCrossrefGoogle Scholar

  • Ichiyama, T., Suenaga, N., Kajimoto, M., Tohyama, J., Isumi, H., Kubota, M., Mori, M., and Furukawa, S. (2008). Serum and CSF levels of cytokines in acute encephalopathy following prolonged febrile seizures. Brain Dev. 30, 47–52.PubMedCrossrefGoogle Scholar

  • Ichiyama, T., Ito, Y., Kubota, M., Yamazaki, T., Nakamura, K., and Furukawa, S. (2009). Serum and cerebrospinal fluid levels of cytokines in acute encephalopathy associated with human herpesvirus-6 infection. Brain Dev. 31, 731–738.PubMedGoogle Scholar

  • Ishizaki, Y., Kira, R., Fukuda, M., Torisu, H., Sakai, Y., Sanefuji, M., Yukaya, N., and Hara, T. (2009). Interleukin-10 is associated with resistance to febrile seizures: genetic association and experimental animal studies. Epilepsia 50, 761–767.CrossrefPubMedGoogle Scholar

  • Jain, M., Aneja, S., Mehta, G., Ray, G.N., Batra, S., and Randhava, V.S. (2000). CSF interleukin-1β, tumor necrosis factor-α and free radicals production in relation to clinical outcome in acute bacterial meningitis. Indian Pediatr. 37, 608–614.PubMedGoogle Scholar

  • Jamali, S., Salzmann, A., Perroud, N., Ponsole-Lenfant, M., Cillario, J., Roll, P., Roeckel-Trevisiol, N., Crespel, A., Balzar, J., Schlachter, K., et al. (2010). Functional variant in complement C3 gene promoter and genetic susceptibility to temporal lobe epilepsy and febrile seizures. PLoS One 5, e12740.Google Scholar

  • Jin, L., Jia, Y., Zhang, B., Xu, Q., Fan, Y., Wu, L., and Shen, Y. (2003). Association analysis of a polymorphism of interleukin 1β (IL-1β) gene with temporal lobe epilepsy in a Chinese population. Epilepsia 44, 1306–1309.Google Scholar

  • Johnson, E.W., Dubovsky, J., Rich, S.S., O’Donovan, C.A., Orr, H.T., Anderson, V.E., Gil-Nagel, A., Ahmann, P., Dokken, C.G., Schneider, D.T., et al. (1998). Evidence for a novel gene for familial febrile convulsions, FEB2, linked to chromosome 19p in an extended family from the Midwest. Hum. Mol. Genet. 7, 63–67.CrossrefGoogle Scholar

  • Kamangar, F., Cheng, C., Abnet, C.C., and Rabkin, C.S. (2006). Interleukin-1B polymorphisms and gastric cancer risk – a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 15, 1920–1928.CrossrefGoogle Scholar

  • Kanemoto, K., Kawasaki, J., Miyamoto, T., Obayashi, H., and Nishimura, M. (2000). Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann. Neurol. 47, 571–574.Google Scholar

  • Kanemoto, K., Kawasaki, J., Yuasa, S., Kumaki, T., Tomohiro, O., Kaji, R., and Nishimura, M. (2003). Increased frequency of interleukin-1β -511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia 44, 796–799.Google Scholar

  • Kauffman, M.A., Moron, D.G., Consalvo, D., Bello, R., and Kochen, S. (2008). Association study between interleukin 1β gene and epileptic disorders: a HuGe review and meta-analysis. Genet. Med. 10, 83–88.PubMedCrossrefGoogle Scholar

  • Kawakami, Y., Fukunaga, Y., Kuwabara, K., Fujita, T., Fujino, O., and Hashimoto, K. (1999a). Clinical and immunological significance of neopterin measurement in cerebrospinal fluid in patients with febrile convulsions. Brain Dev. 21, 458–460.CrossrefPubMedGoogle Scholar

  • Kawakami, Y., Fukunaga, Y., Kuwabara, K., Fujita, T., Fujino, O., and Hashimoto, K. (1999b). Cerebrospinal fluid levels of neopterin in child patients with neurological diseases-in correlation with IFN-γ or TNF-α. Pteridines 10, 27–31.Google Scholar

  • Khoshdel, A., Kheiri, S., Habibian, R., Nozari, A., and Baradaran, A. (2012). Lack of association between TNF-α gene polymorphisms at position -308A, -850T and risk of simple febrile convulsion in pediatric patients. Adv. Biomed. Res. 1, 85.Google Scholar

  • Kim, S.E., Kim, H.G., Kim, Y.H., Choi, B.J., Hwang, H.S., Bin, J.H., Chung, S.Y., and Lee, I.G. (2008). Brain-derived neurotrophic factor (BDNF) SNP 6265 polymorphisms in febrile seizure and GEFS+. J. Kor. Child Neurol. Soc. 16, 114–120.Google Scholar

  • Kinirons, P., Cavalleri, G.L., Shahwan, A., Wood, N.W., Goldstein, D.B., Sisodiya, S.M., Delanty, N., and Doherty, C.P. (2006). Examining the role of common genetic variation in the γ2 subunit of the GABAA receptor in epilepsy using tagging SNPs. Epilepsy Res. 70, 229–238.CrossrefGoogle Scholar

  • Kira, R., Torisu, H., Takemoto, M., Nomura, A., Sakai, Y., Sanefuji, M., Sakamoto, K., Matsumoto, S., Gondo, K., and Hara, T. (2005). Genetic susceptibility to simple febrile seizures: interleukin-1β promoter polymorphisms are associated with sporadic cases. Neurosci. Lett. 384, 239–244.Google Scholar

  • Kira, R., Ishizaki, Y., Torisu, H., Sanefuji, M., Takemoto, M., Sakamoto, K., Matsumoto, S., Yamaguchi, Y., Yukaya, N., Sakai, Y., et al. (2010). Genetic susceptibility to febrile seizures: case-control association studies. Brain Dev. 32, 57–63.PubMedCrossrefGoogle Scholar

  • Kjeldsen, M.J., Kyvik, K.O., Friis, M.L., and Christensen, K. (2002). Genetic and environmental factors in febrile seizures: a Danish population-based twin study. Epilepsy Res. 51, 167–177.CrossrefPubMedGoogle Scholar

  • Kjeldsen, M.J., Corey, L.A., Solaas, M.H., Friis, M.L., Harris, J.R., Kyvik, K.O., Christensen, K., and Pellock, J.M. (2005). Genetic factors in seizures: a population-based study of 47,626 US, Norwegian and Danish twin pairs. Twin Res. Hum. Genet. 8, 138–147.Google Scholar

  • Klein, N.P., Lewis, E., Baxter, R., Weintraub, E., Glanz, J., Naleway, A., Jackson, L.A., Nordin, J., Lieu, T., and Belongia, E.A. (2012). Measles-containing vaccines and febrile seizures in children age 4 to 6 years. Pediatrics 129, 809–814.CrossrefPubMedGoogle Scholar

  • Kluger, M.J. (1991). Fever: role of pyrogens and cryogens. Physiol. Rev. 71, 93–127.PubMedGoogle Scholar

  • Knudsen, F.U. (1985). Recurrence risk after first febrile seizure and effect of short term diazepam prophylaxis. Arch. Dis. Child 60, 1045–1049.CrossrefPubMedGoogle Scholar

  • Kumari, P.L., Nair, M.K.C., Nair, S.M., Kailas, L., and Geetha, S. (2012). Iron deficiency as a risk factor for simple febrile seizures-a case control study. Indian Pediatr. 49, 17–19.CrossrefPubMedGoogle Scholar

  • Kundu, G.K., Rabin, F., Nandi, E.R., Sheikh, N., and Akhter, S. (2012). Etiology and risk factors of febrile seizure – an update. Bangladesh J. Child Health 34, 103–112.Google Scholar

  • Lahat, E., Livne, M., Barr, J., and Katz, Y. (1997). Interleukin-1β levels in serum and cerebrospinal fluid of children with febrile seizures. Pediatr. Neurol. 17, 34–36.Google Scholar

  • Le Gal, F., Salzmann, A., Crespel, A., and Malafosse, A. (2011). Replication of association between a SCN1A splice variant and febrile seizures. Epilepsia 52, e135–e138.Google Scholar

  • Lehtimaki, K.A., Keranen, T., Huhtala, H., Hurme, M., Ollikainen, J., Honkaniemi, J., Palmio, J., and Peltola, J. (2004). Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration. J. Neuroimmunol. 152, 121–125.Google Scholar

  • Lehtimaki, K.A., Liimatainen, S., Peltola, J., and Arvio, M. (2011). The serum level of interleukin-6 in patients with intellectual disability and refractory epilepsy. Epilepsy Res. 95, 184–187.PubMedGoogle Scholar

  • Lehtimäki, K.A., Keränen, T., Palmio, J., Mäkinen, R., Hurme, M., Honkaniemi, J., and Peltola, J. (2007). Increased plasma levels of cytokines after seizures in localization-related epilepsy. Acta Neurol. Scand. 116, 226–230.PubMedCrossrefGoogle Scholar

  • Lehtimäki, K., Keränen, T., Huuhka, M., Palmio, J., Hurme, M., Leinonen, E., and Peltola, J. (2008). Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder. J. ECT 24, 88–91.CrossrefGoogle Scholar

  • Lehtimäki, K.A., Keränen, T., Palmio, J., and Peltola, J. (2010). Levels of IL-1β and IL-1ra in cerebrospinal fluid of human patients after single and prolonged seizures. Neuroimmunomodulation 17, 19–22.Google Scholar

  • Li, Y., Ma, Y., Chen, Z., Tian, G., Zou, L., Fang, F., and Qi, Y. (2008). Association study on simple febrile seizures and casein kinase 1, gamma 1 gene. J. Appl. Clin. Pediatr. 4.Google Scholar

  • Li, X., Wang, R., Wang, X., Xue, X., Ran, D., and Wang, S. (2013). Relevance of IL-6 and MMP-9 to cerebral arteriovenous malformation and hemorrhage. Mol. Med. Rep. 7, 1261–1266.PubMedGoogle Scholar

  • Liimatainen, S., Fallah, M., Kharazmi, E., Peltola, M., and Peltola, J. (2009). Interleukin-6 levels are increased in temporal lobe epilepsy but not in extra-temporal lobe epilepsy. J. Neurol. 256, 796–802.CrossrefGoogle Scholar

  • Lin, L.-C., Lin, H.-S., and Yang, R.-C. (2007). Neuropeptide Y gene polymorphism and plasma neuropeptide Y level in febrile seizure patients in Taiwan. Kaohsiung J. Med. Sci. 23, 560–565.Google Scholar

  • Ling, Z.D., Yeoh, E., Webb, B.T., Farrell, K., Doucette, J., and Matheson, D.S. (1993). Intravenous immunoglobulin induces interferon-γ and interleukin-6 in vivo. J. Clin. Immunol. 13, 302–309.Google Scholar

  • Liu, X., Wang, Z., Yu, J., Lei, G., and Wang, S. (2010). Three polymorphisms in interleukin-1β gene and risk for breast cancer: a meta-analysis. Breast Cancer Res. Treat. 124, 821–825.CrossrefGoogle Scholar

  • Lukaszewicz, A.C., Faivre, V., Villa, F., and Payen, D. (2010). Anti-inflammatory profile of circulating immune cells after surgery for seizure. Min. Anestesiol. 76, 477–484.Google Scholar

  • Ma, Y.N., Hao, L., Niu, S.L., Xu, Y.F., Zhang, Y., Pei, P., Bu, D.F., and Qi, Y. (2004). Five single nucleotide polymorphisms of casein kinase I gamma 2 gene in children with familial febrile convulsions. Chin. J. Med. Genet. 21, 347–350.Google Scholar

  • Majoie, H.J.M., Rijkers, K., Berfelo, M.W., Hulsman, J., Myint, A., Schwarz, M., and Vles, J.S.H. (2010). Vagus nerve stimulation in refractory epilepsy: effects on pro-and anti-inflammatory cytokines in peripheral blood. Neuroimmunomodulation 18, 52–56.PubMedGoogle Scholar

  • Makis, A.C., Tzoufi, M., Kateri, M.D., Bourantas, K.I., and Papadopoulou, Z.L. (2005). Valproate-induced eosinophilia in children with epilepsy: role of interleukin-5. J. Child Neurol. 20, 150–152.Google Scholar

  • Mantegazza, M., Gambardella, A., Rusconi, R., Schiavon, E., Annesi, F., Cassulini, R.R., Labate, A., Carrideo, S., Chifari, R., Canevini, M.P., et al. (2005). Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures. Proc. Natl. Acad. Sci. USA. 102, 18177–18182.Google Scholar

  • Martinos, M.M., Yoong, M., Patil, S., Chin, R.F.M., Neville, B.G., Scott, R.C., and de Haan, M. (2012). Recognition memory is impaired in children after prolonged febrile seizures. Brain 135, 3153–3164.CrossrefGoogle Scholar

  • Masuyama, T., Matsuo, M., Ichimaru, T., Ishii, K., Tsuchiya, K., and Hamasaki, Y. (2002). Possible contribution of interferon-α to febrile seizures in influenza. Pediatr. Neurol. 27, 289–292.CrossrefPubMedGoogle Scholar

  • Mathieu, O., Picot, M.-C., Gelisse, P., Breton, H., Demoly, P., and Hillaire-Buys, D. (2011). Effects of carbamazepine and metabolites on IL-2, IL-5, IL-6, IL-10 and IFN-g secretion in epileptic patients: the influence of co-medication. Pharmacol. Rep. 63, 86–94.Google Scholar

  • Matsumura, K., Cao, C., Ozaki, M., Morii, H., Nakadate, K., and Watanabe, Y. (1998). Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: light and electron microscopic immunocytochemical studies. J. Neurosci. 18, 6279–6289.Google Scholar

  • Matsuo, M., Sasaki, K., Ichimaru, T., Nakazato, S., and Hamasaki, Y. (2006). Increased IL-1β production from dsRNA-stimulated leukocytes in febrile seizures. Pediatr. Neurol. 35, 102–106.PubMedCrossrefGoogle Scholar

  • McIntyre, K.W., Stepan, G.J., Kolinsky, K.D., Benjamin, W.R., Plocinski, J.M., Kaffka, K.L., Campen, C.A., Chizzonite, R.A., and Kilian, P.L. (1991). Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J. Exp. Med. 173, 931–939.Google Scholar

  • Miller, L.L., Pellock, J.M., DeLorenzo, R.J., Meyer, J.M., and Corey, L.A. (1998). Univariate genetic analyses of epilepsy and seizures in a population-based twin study: the Virginia Twin Registry. Genet. Epidemiol. 15, 33–49.CrossrefGoogle Scholar

  • Miller, L.L., Pellock, J.M., Boggs, J.G., DeLorenzo, R.J., Meyer, J.M., and Corey, L.A. (1999). Epilepsy and seizure occurrence in a population-based sample of Virginian twins and their families. Epilepsy Res. 34, 135–143.CrossrefGoogle Scholar

  • Miller, B.J., Buckley, P., Seabolt, W., Mellor, A., and Kirkpatrick, B. (2011). Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 70, 663–671.CrossrefPubMedGoogle Scholar

  • Mine, J., Takahashi, Y., Mogami, Y., Ikeda, H., Kubota, Y., and Imai, K. (2013). Characteristics of epilepsy and immunological markers in epileptic patients after influenza associated encephalopathy. Neurol. Asia 18, 35–45.Google Scholar

  • Moulard, B., Guipponi, M., Chaigne, D., Mouthon, D., Buresi, C., and Malafosse, A. (1999). Identification of a new locus for generalized epilepsy with febrile seizures plus (GEFS+) on chromosome 2q24-q33. Am. J. Hum. Genet. 65, 1396–1400.Google Scholar

  • Mulley, J., Heron, S., Scheffer, I., and Berkovic, S. (2004). Febrile convulsions and genetic susceptibility: role of the neuronal nicotinic acetylcholine receptor α4 subunit. Epilepsia 45, 561–562.CrossrefGoogle Scholar

  • Nabbout, R., Prud’homme, J.F., Herman, A., Feingold, J., Brice, A., Dulac, O., and LeGuern, E. (2002). A locus for simple pure febrile seizures maps to chromosome 6q22-q24. Brain 125, 2668–2680.Google Scholar

  • Nabbout, R., Baulac, S., Desguerre, I., Bahi-Buisson, N., Chiron, C., Ruberg, M., Dulac, O., and LeGuern, E. (2007). New locus for febrile seizures with absence epilepsy on 3p and a possible modifier gene on 18p. Neurology 68, 1374–1381.CrossrefGoogle Scholar

  • Nakayama, J. and Arinami, T. (2006). Molecular genetics of febrile seizures. Epilepsy Res. 70, 190–198.CrossrefGoogle Scholar

  • Nakayama, J., Hamano, K., Iwasaki, N., Nakahara, S., Horigome, Y., Saitoh, H., Aoki, T., Maki, T., Kikuchi, M., Migita, T., et al. (2000). Significant evidence for linkage of febrile seizures to chromosome 5q14-q15. Hum. Mol. Genet. 9, 87–91.CrossrefGoogle Scholar

  • Nakayama, J., Yamamoto, N., Hamano, K., Iwasaki, N., Ohta, M., Nakahara, S., Horigome, Y., Nakahara, C., Noguchi, E., and Shiono, J. (2002). Failure to find evidence for association between voltage-gated sodium channel gene SCN2A variants and febrile seizures in humans. Neurosci. Lett. 329, 249–251.CrossrefGoogle Scholar

  • Nakayama, J., Hamano, K., Iwasaki, N., Ohta, M., Nakahara, S., Matsui, A., and Arinami, T. (2003a). Mutation analysis of the leucine-rich, glioma inactivated 1 gene (LGI1) in Japanese febrile seizure patients. Neuropediatrics 34, 234–236.Google Scholar

  • Nakayama, J., Hamano, K., Noguchi, E., Horiuchi Y, Iwasaki, N., Ohta, M., Nakahara, S., Naoi, T., Matsui, A., and Arinami, T. (2003b). Failure to find causal mutations in the GABAA-receptor γ2 subunit (GABRG2) gene in Japanese febrile seizure patients. Neurosci. Lett. 343, 117–120.CrossrefGoogle Scholar

  • Nakayama, J., Yamamoto, N., Hamano, K., Iwasaki, N., Ohta, M., Nakahara, S., Matsui, A., Noguchi, E., and Arinami, T. (2004). Linkage and association of febrile seizures to the IMPA2 gene on human chromosome 18. Neurology 63, 1803–1807.CrossrefGoogle Scholar

  • Nelson, K.B. and Ellenberg, J.H. (1978). Prognosis in children with febrile seizures. Pediatrics 61, 720–727.PubMedGoogle Scholar

  • Netea, M.G., Kullberg, B.J., and Van der Meer, J.W.M. (2000). Circulating cytokines as mediators of fever. Clin. Infect. Dis. 31, S178–S184.CrossrefGoogle Scholar

  • Nowak, M., Bauer, S., Haag, A., Cepok, S., Todorova-Rudolph, A., Tackenberg, B., Norwood, B., Oertel, W.H., Rosenow, F., Hemmer, B., et al. (2011). Interictal alterations of cytokines and leukocytes in patients with active epilepsy. Brain Behav. Immun. 25, 423–428.PubMedCrossrefGoogle Scholar

  • Nur, B., Sahinturk, D., Coskun, M., Duman, O., Yavuzer, U., and Haspolat, S. (2012a). Single nucleotide polymorphism and production of IL-1β and IL-10 cytokines in febrile seizures. Neuropediatrics 43, 194–200.Google Scholar

  • Nur, B.G., Kahramaner, Z., Duman, O., Dundar, N.O., Sallakcı, N., Yavuzer, U., and Haspolat, S. (2012b). Interleukin-6 gene polymorphism in febrile seizures. Pediatr. Neurol. 46, 36–38.CrossrefPubMedGoogle Scholar

  • Offringa, M. and Newton, R. (2013). Prophylactic drug management for febrile seizures in children (Review). (Evid. Base. Child Health) Cochrane Rev. J. 8, 1376–1485.CrossrefGoogle Scholar

  • Özaydın, E., Arhan, E., Cetinkaya, B., Özdel, S., Değerliyurt, A., Güven, A., and Köse, G. (2012). Differences in iron deficiency anemia and mean platelet volume between children with simple and complex febrile seizures. Seizure 21, 211–214.CrossrefPubMedGoogle Scholar

  • Ozkara, C., Uzan, M., Tanriverdi, T., Baykara, O., Ekinci, B., Yeni, N., Kafadar, A., and Buyru, N. (2006). Lack of association between IL-1β/α gene polymorphisms and temporal lobe epilepsy with hippocampal sclerosis. Seizure 15, 288–291.CrossrefGoogle Scholar

  • Pascual, V., Allantaz, F., Arce, E., Punaro, M., and Banchereau, J. (2005). Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J. Exp. Med. 201, 1479–1486.Google Scholar

  • Peiffer, A., Thompson, J., Charlier, C., Otterud, B., Varvil, T., Pappas, C., Barnitz, C., Gruenthal, K., Kuhn, R., and Leppert, M. (1999). A locus for febrile seizures (FEB3) maps to chromosome 2q23-24. Ann. Neurol. 46, 671–678.Google Scholar

  • Peltola, J., Hurme, M., Miettinen, A., and Keränen, T. (1998). Elevated levels of interleukin-6 may occur in cerebrospinal fluid from patients with recent epileptic seizures. Epilepsy Res. 31, 129–133.CrossrefPubMedGoogle Scholar

  • Peltola, J., Palmio, J., Korhonen, L., Suhonen, J., Miettinen, A., Hurme, M., Lindholm, D., and Keränen, T. (2000). Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res. 41, 205–211.CrossrefPubMedGoogle Scholar

  • Peltola, J., Keränen, T., Rainesalo, S., and Hurme, M. (2001). Polymorphism of the interleukin-1 gene complex in localization-related epilepsy. Ann. Neurol. 50, 275–276.CrossrefPubMedGoogle Scholar

  • Peltola, J., Laaksonen, J., Haapala, A.M., Hurme, M., Rainesalo, S., and Keranen, T. (2002). Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels. Seizure 11, 44–46.CrossrefPubMedGoogle Scholar

  • Pollard, J.R., Eidelman, O., Mueller, G.P., Dalgard, C.L., Crino, P.B., Anderson, C.T., Brand, E.J., Burakgazi, E., Ivaturi, S.K., and Pollard, H.B. (2012). The TARC/sICAM5 ratio in patient plasma is a candidate biomarker for drug resistant epilepsy. Front. Neurol. 3, 181.Google Scholar

  • Ponnala, S., Chaudhari, J.R., Jaleel, M.A., Bhiladvala, D., Kaipa, P.R., Das, U.N., and Hasan, Q. (2012). Role of MDR1 C3435T and GABRG2 C588T gene polymorphisms in seizure occurrence and MDR1 effect on anti-epileptic drug (phenytoin) absorption. Genet. Test. Mol. Biomarkers 16, 550–557.Google Scholar

  • Qi, L., van Dam, R.M., Meigs, J.B., Manson, J.E., Hunter, D., and Hu, F.B. (2006). Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis. Hum. Mol. Genet. 15, 1914–1920.Google Scholar

  • Rainero, I., Bo, M., Ferrero, M., Valfrè, W., Vaula, G., and Pinessi, L. (2004). Association between the interleukin-1α gene and Alzheimer’s disease: a meta-analysis. Neurobiol. Aging 25, 1293–1298.CrossrefGoogle Scholar

  • Represa, A. and Ben-Ari, Y. (2005). Trophic actions of GABA on neuronal development. Trends Neurosci. 28, 278–283.CrossrefGoogle Scholar

  • Sacchetti, E., Bocchio-Chiavetto, L., Valsecchi, P., Scassellati, C., Pasqualetti, P., Bonvicini, C., Corsini, P., Rossi, G., Cesana, B.M., and Barlati, S. (2007). -G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: meta-analysis plus association study. Brain Behav. Immun. 21, 450–457.Google Scholar

  • Salam, S.A., Rahman, H.A., and Karam, R. (2012). GABRG2 gene polymorphisms in Egyptian children with simple febrile seizures. Indian J. Pediatr. 79, 1514–1516.CrossrefGoogle Scholar

  • Salzmann, A., Guipponi, M., Lyons, P.J., Fricker, L.D., Sapio, M., Lambercy, C., Buresi, C., Ouled Amar Bencheikh, B., Lahjouji, F., Ouazzani, R., et al. (2012). Carboxypeptidase A6 gene (CPA6) mutations in a recessive familial form of febrile seizures and temporal lobe epilepsy and in sporadic temporal lobe epilepsy. Hum. Mutat. 33, 124–135.CrossrefGoogle Scholar

  • Sasidaran, K., Singhi, S., and Singhi, P. (2012). Management of acute seizure and status epilepticus in pediatric emergency. Indian J. Pediatr. 79, 510–517.CrossrefPubMedGoogle Scholar

  • Schlachter, K., Gruber-Sedlmayr, U., Stogmann, E., Lausecker, M., Hotzy, C., Balzar, J., Schuh, E., Baumgartner, C., Mueller, J.C., Illig, T., et al. (2009). A splice site variant in the sodium channel gene SCN1A confers risk of febrile seizures. Neurology 72, 974–978.Google Scholar

  • Scott, J.A.G., Wonodi, C., Moïsi, J.C., Deloria-Knoll, M., DeLuca, A.N., Karron, R.A., Bhat, N., Murdoch, D.R., Crawley, J., and Levine, O.S. (2012). The definition of pneumonia, the assessment of severity, and clinical standardization in the Pneumonia Etiology Research for Child Health Study. Clin. Infect. Dis. 54, S109–S116.CrossrefGoogle Scholar

  • Serdaroğlu, G., Alpman, A., Tosun, A., Pehlıvan, S., Özkınay, F., Tekgül, H., and Gökben, S. (2009). Febrile seizures: interleukin 1β and interleukin-1 receptor antagonist polymorphisms. Pediatr. Neurol. 40, 113–116.Google Scholar

  • Shu-hua, L., Chao-feng, H., and Te-chang, L. (2006). Relationship between the children interleukin 1β(-511) gene polymorphisms and susceptibility to febrile seizures. Chin. J. Pathophysiol. 22, 1168–1170.Google Scholar

  • Sinha, S., Patil, S.A., Jayalekshmy, V., and Satishchandra, P. (2008). Do cytokines have any role in epilepsy? Epilepsy Res. 82, 171–176.PubMedCrossrefGoogle Scholar

  • Staley, K.J., Soldo, B.L., and Proctor, W.R. (1995). Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors. Science (New York NY) 269, 977–981.CrossrefGoogle Scholar

  • Stoeck, K., Bodemer, M., and Zerr, I. (2006). Pro- and anti-inflammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease. J. Neuroimmunol. 172, 175–181.CrossrefGoogle Scholar

  • Swardfager, W., Lanctôt, K., Rothenburg, L., Wong, A., Cappell, J., and Herrmann, N. (2010). A meta-analysis of cytokines in Alzheimer’s disease. Biol. Psychiatry 68, 930–941.PubMedCrossrefGoogle Scholar

  • Takahashi, Y., Mine, J., Kubota, Y., Yamazaki, E., and Fujiwara, T. (2009). A substantial number of Rasmussen syndrome patients have increased IgG, CD4+ T cells, TNFα, and granzyme B in CSF. Epilepsia 50, 1419–1431.CrossrefGoogle Scholar

  • Takahashi, Y., Imai, K., Ikeda, H., Kubota, Y., Yamazaki, E., and Susa, F. (2013). Open study of pranlukast add-on therapy in intractable partial epilepsy. Brain Dev. 35, 236–244.CrossrefPubMedGoogle Scholar

  • Teran, C.G., Medows, M., Wong, S.H., Rodriguez, L., and Varghese, R. (2012). Febrile seizures: current role of the laboratory investigation and source of the fever in the diagnostic approach. Pediatr. Emerg. Care 28, 493–497.CrossrefGoogle Scholar

  • Thakkinstian, A., McElduff, P., D’Este, C., Duffy, D., and Attia, J. (2005). A method for meta-analysis of molecular association studies. Stat. Med. 24, 1291–1306.CrossrefGoogle Scholar

  • Tilgen, N., Pfeiffer, H., Cobilanschi, J., Rau, B., Horvath, S., Elger, C.E., Propping, P., and Heils, A. (2002). Association analysis between the human interleukin 1β (-511) gene polymorphism and susceptibility to febrile convulsions. Neurosci. Lett. 334, 68–70.Google Scholar

  • Tiwari, P., Dwivedi, R., Mansoori, N., Alam, R., Chauhan, U.K., Tripathi, M., and Mukhopadhyay, A.K. (2012). Do gene polymorphism in IL-1β, TNF-α and IL-6 influence therapeutic response in patients with drug refractory epilepsy? Epilepsy Res. 101, 261–267.Google Scholar

  • Tomoum, H.Y., Badawy, N.M., Mostafa, A.A., and Harb, M.Y. (2007). Plasma interleukin-1β levels in children with febrile seizures. J. Child Neurol. 22, 689–692.CrossrefGoogle Scholar

  • Treiman, D.M. (2001). GABAergic mechanisms in epilepsy. Epilepsia 42, 8–12.PubMedCrossrefGoogle Scholar

  • Tsai, F.-J., Hsieh, Y.-Y., Chang, C.-C., Lin C.-C., and Tsai, C.-H. (2002a). Polymorphisms for interleukin 1β exon 5 and interleukin 1 receptor antagonist in Taiwanese children with febrile convulsions. Arch. Pediatr. Adolesc. Med. 156, 545–548.CrossrefPubMedGoogle Scholar

  • Tsai, F.-J., Chou, I.C., Hsieh, Y.-Y., Lee, C.-C., Lin, C.-C., and Tsai, C.-H. (2002b). Interleukin-4 intron 3 polymorphism is not related to susceptibility to febrile seizures. Pediatr. Neurol. 27, 271–274.Google Scholar

  • Tsuboi, T. (1987). Genetic analysis of febrile convulsions: twin and family studies. Hum. Genet. 75, 7–14.PubMedGoogle Scholar

  • Uludag, I.F., Bilgin, S., Zorlu, Y., Tuna, G., and Kirkali, G. (2013). Interleukin-6, interleukin-1beta and interleukin-1 receptor antagonist levels in epileptic seizures. Seizure 22, 457–461.CrossrefGoogle Scholar

  • van Esch, A., Steyerberg, E.W., van Duijn, C.M., Offringa, M., Derksen-Lubsen, G., van Steensel-Moll, H.A., and van Esch, A. (1998). Prediction of febrile seizures in siblings: a practical approach. Eur. J. Pediatr. 157, 340–344.CrossrefGoogle Scholar

  • Verity, C.M., Butler, N.R., and Golding, J. (1985). Febrile convulsions in a national cohort followed up from birth. I. Prevalence and recurrence in the first five years of life. Br. Med. J. 290, 1307–1310.CrossrefGoogle Scholar

  • Vezzani, A., Balosso, S., and Ravizza, T. (2008). The role of cytokines in the pathophysiology of epilepsy. Brain Behav. Immun. 22, 797–803.PubMedCrossrefGoogle Scholar

  • Vezzani, A., French, J., Bartfai, T., and Baram, T.Z. (2010). The role of inflammation in epilepsy. Nat. Rev. Neurol. 7, 31–40.PubMedGoogle Scholar

  • Vigers, G.P.A., Anderson, L.J., Caffes, P., and Brandhuber, B.J. (1997). Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1β. Nature 386, 190–194.CrossrefGoogle Scholar

  • Virta, M., Hurme, M., and Helminen, M. (2002a). Increased frequency of interleukin-1β (-511) allele 2 in febrile seizures. Pediatr. Neurol. 26, 192–195.CrossrefGoogle Scholar

  • Virta, M., Hurme, M., and Helminen, M. (2002b). Increased plasma levels of pro- and anti-inflammatory cytokines in patients with febrile seizures. Epilepsia 43, 920–923.PubMedCrossrefGoogle Scholar

  • Visser, A.M., Jaddoe, V.W., Ghassabian, A., Schenk, J.J., Verhulst, F.C., Hofman, A., Tiemeier, H., Moll, H.A., and Arts, W.F.M. (2012). Febrile seizures and behavioural and cognitive outcomes in preschool children: the Generation R Study. Dev. Med. Child Neurol. 54, 1006–1011.PubMedCrossrefGoogle Scholar

  • Viviani, B., Bartesaghi, S., Gardoni, F., Vezzani, A., Behrens, M.M., Bartfai, T., Binaglia, M., Corsini, E., Di Luca, M., and Galli, C.L. (2003). Interleukin-1β enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 23, 8692–8700.Google Scholar

  • Wallace, R.H., Berkovic, S.F., Howell, R.A., Sutherland, G.R., and Mulley, J.C. (1996). Suggestion of a major gene for familial febrile convulsions mapping to 8q13-21. J. Med. Genet. 33, 308–312.Google Scholar

  • Wang, S., Cheng, Q., Malik, S., and Yang, J. (2000). Interleukin-1β inhibits γ-aminobutyric acid type A (GABAA) receptor current in cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 292, 497–504.Google Scholar

  • Wang, P., Xia, H.H.-X., Zhang, J.-Y., Dai, L.-P., Xu, X.-Q., and Wang, K.-J. (2007a). Association of interleukin-1 gene polymorphisms with gastric cancer: a meta-analysis. Int. J. Cancer 120, 552–562.CrossrefPubMedGoogle Scholar

  • Wang, X., Xu, M., and Du, L. (2007b). Association analysis of γ2 subunit of γ-aminobutyric acid (GABA) type A receptor and voltage-gated sodium channel type II α-polypeptide gene mutation in southern Chinese children with febrile seizures. J. Child Neurol. 22, 714–719.CrossrefGoogle Scholar

  • Waruiru, C. and Appleton, R. (2004). Febrile seizures: an update. Arch. Dis. Child 89, 751–756.PubMedCrossrefGoogle Scholar

  • Wendorff, J. and Zeman, K. (2011). Immunology of febrile seizures. Neurol. Dziec. 20, 41–46.Google Scholar

  • Wiebe, S., Blume, W.T., Girvin, J.P., and Eliasziw, M. (2001). A randomized, controlled trial of surgery for temporal-lobe epilepsy. N. Engl. J. Med. 345, 311–318.CrossrefGoogle Scholar

  • Wu, Z.Q., Sun, L., Sun, Y.H., Ren, C., Jiang, Y.H., and Lv, X.L. (2012). Interleukin 1beta -511 C/T gene polymorphism and susceptibility to febrile seizures: a meta-analysis. Mol. Biol. Rep. 39, 5401–5407.CrossrefGoogle Scholar

  • Xue, H., Lin, B., Ni, P., Xu, H., and Huang, G. (2010). Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis. J. Gastroenterol. Hepatol. 25, 1604–1617.CrossrefGoogle Scholar

  • Yamanaka, G., Kawashima, H., Suganami, Y., Watanabe, C., Watanabe, Y., Miyajima, T., Takekuma, K., Oguchi, S., and Hoshika, A. (2006). Diagnostic and predictive value of CSF d-ROM level in influenza virus-associated encephalopathy. J. Neurol. Sci. 243, 71–75.CrossrefGoogle Scholar

  • Yamanaka, G., Kawashima, H., Oana, S., Ishida, Y., Miyajima, T., Kashiwagi, Y., and Hoshika, A. (2010). Increased level of serum interleukin-1 receptor antagonist subsequent to resolution of clinical symptoms in patients with West syndrome. J. Neurol. Sci. 298, 106–109.CrossrefGoogle Scholar

  • Yinan, M., Yu, Q., Zhiyue, C., Jianjun, L., Lie, H., Liping, Z., Jianhui, Z., Fang, S., Dingfang, B., Qing, L., et al. (2004). Polymorphisms of casein kinase I gamma 2 gene associated with simple febrile seizures in Chinese Han population. Neurosci. Lett. 368, 2–6.CrossrefPubMedGoogle Scholar

  • Yinan, M., Yu, Q., Zhiyue, C., Liping, Z., Fang, F., Liwen, W., Fuying, S., Jianhui, Z., Dingfang, B., and Tianjun, W. (2006). HCN2, NRTN, CAPS and GPX4 genes are not associated with simple febrile seizures in Chinese Han population. J. Pediatr. Neurol. 4, 83–87.Google Scholar

  • Yoon, J.W., Choen, E.J., and Lee, Y.H. (2008). Polymorphisms of interleukin-1β promoter in simple febrile seizures. Kor. J. Pediatr. 51, 1007–1011.Google Scholar

  • Yu, N., Di, Q., Hu, Y., Zhang, Y.-F., Su, L.-Y., Liu, X.-H., and Li, L.-C. (2012). A meta-analysis of pro-inflammatory cytokines in the plasma of epileptic patients with recent seizure. Neurosci. Lett. 514, 110–115.PubMedCrossrefGoogle Scholar

  • Zareifar, S., Hosseinzadeh, H.R., and Cohan, N. (2012). Association between iron status and febrile seizures in children. Seizure 21, 603–605.PubMedCrossrefGoogle Scholar

  • Zhao, F., Liu, X.-M., Ke, X.-Y., Ming, M., Gui, W.-X., Zhao, D.-C., and Wang, D.-B. (2010). Association of febrile seizures and human myo-inositol monophosphatase 2 gene. J. Appl. Clin. Pediatr. 12.Google Scholar

About the article

Corresponding author: Nima Rezaei, Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Dr. Qarib Street, Keshavarz Boulevard, Tehran 14194, Iran, e-mail: ; Molecular Immunology Research Center; and Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran 14194, Iran; and Department of Infection and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, S10 2TN, UK


Received: 2013-10-20

Accepted: 2013-12-26

Published Online: 2014-02-07

Published in Print: 2014-04-01


Citation Information: Reviews in the Neurosciences, Volume 25, Issue 2, Pages 281–305, ISSN (Online) 2191-0200, ISSN (Print) 0334-1763, DOI: https://doi.org/10.1515/revneuro-2013-0045.

Export Citation

©2014 by Walter de Gruyter Berlin/Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Man Amanat, Roland Thijs, Mona Salehi, and Josemir W. Sander
Seizure, 2018
[2]
Zhigang Liu, Xiangxin Li, Meipin Zhang, Xiaofei Huang, Jun Bai, Zhiwei Pan, Xiuxian Lin, Dongni Yu, Huaping Zeng, Ruiping Wan, and Xingguang Ye
Scientific Reports, 2018, Volume 8, Number 1
[3]
John F. Bowyer, Karen M. Tranter, Bonnie Robinson, Joseph P. Hanig, Madeline Faubion, and Sumit Sarkar
NeuroToxicology, 2018
[4]
Aram Kwon, Byung Ok Kwak, Kyungmin Kim, Jongseok Ha, Soo-Jin Kim, Sun Hwan Bae, Jae Sung Son, Soo-Nyung Kim, and Ran Lee
Seizure, 2018, Volume 59, Page 5
[5]
Yan Lin, Cheng Zheng, Ying Liu, Lei Wang, and Haibin Gong
Experimental and Therapeutic Medicine, 2016, Volume 12, Number 3, Page 1349
[6]
Benjamin D. S. Clarkson, Robert J. Kahoud, Christina B. McCarthy, and Charles L. Howe
Scientific Reports, 2017, Volume 7, Number 1
[8]
Amene Saghazadeh and Nima Rezaei
Biomedicine & Pharmacotherapy, 2017, Volume 92, Page 128
[9]
Amene Saghazadeh and Nima Rezaei
Expert Review of Clinical Immunology, 2017, Volume 13, Number 9, Page 845
[10]
Jiaying Wu, Yuyu Zhang, Hongyu Yang, Yuefeng Rao, Jing Miao, and Xiaoyang Lu
Canadian Journal of Infectious Diseases and Medical Microbiology, 2016, Volume 2016, Page 1
[11]
Kelvin K.W. To, Susanna K.P. Lau, Kwok-Hei Chan, Ka-Yi Mok, Hayes K.H. Luk, Cyril C.Y. Yip, Yat-Kwan Ma, Lorraine H.Y. Sinn, Sonia H.Y. Lam, Chun-Wai Ngai, Ivan F.N. Hung, Kwok-Hung Chan, and Kwok-Yung Yuen
Journal of Clinical Virology, 2016, Volume 77, Page 85
[12]
S. Soltani, A. Saghazadeh, M. Movahedi, M. Tavakol, M. Sadr, E. Farhadi, and N. Rezaei
Allergologia et Immunopathologia, 2016, Volume 44, Number 4, Page 341
[13]
Kjell Heuser, Karl O. Nakken, Inger Sandvig, and Erik Taubøll
Tidsskrift for Den norske legeforening, 2016, Volume 136, Number 1, Page 36
[14]
Kenji Sudo, Yosuke Takezawa, Shinichi Kohsaka, and Kazuyuki Nakajima
Brain Research, 2015, Volume 1625, Page 121
[15]
Amin Shahrokhi, Ameneh Zare-Shahabadi, Samaneh Soltani, Farin Soleimani, Roshanak Vameghi, Arian Rahimi Konjkav, Parviz Karimi, Pegah Katibeh, Mohammad Vafaei, Samaneh Zoghi, Mahmoud Reza Ashrafi, and Nima Rezaei
Seizure, 2015, Volume 29, Page 148
[16]
Essam Eldin Mohamed Nour Eldin, Hosam Abdel-Fattah Elshebiny, Tarek Mostafa Mohamed, Mohamed Abdel-Azim Abdel-Aziz, and Mahmoud Zaki El-Readi
International Journal of Neuroscience, 2016, Volume 126, Number 2, Page 105

Comments (0)

Please log in or register to comment.
Log in